Advances in ovarian cancer screening and early detection: from biomarkers to multivariate index assays
It is also critical to clearly distinguish between diagnostic and screening applications, as each requires different performance characteristics, regulatory pathways, and target populations, and no ovarian cancer screening test is currently approved for routine use.
Authors
- A Gentry-Maharaj
- Gregory E. Rice (ORCID: https://orcid.org/0000-0001-7177-0246)
- Melissa Razo-Azamar
- Carlos Salomón (ORCID: https://orcid.org/0000-0003-4474-0046)
- Usha Menon
Institutions
- The University of Queensland (AU)
- Instituto de Novas Tecnologias (PT)
- University College London (GB)
Publication Details
- Journal
- Expert Review of Molecular Diagnostics
- Published
- 2026-01-02
- DOI
- https://doi.org/10.1080/14737159.2025.2608820
- Primary Topic
- Ovarian cancer diagnosis and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00